• Composition and format AOD 9604 (5 mg) is a synthetic peptide fragment supplied as a lyophilized powder in a single vial. Each vial contains 5 mg of AOD 9604. The batch-specific Certificate of Analysis (COA) provides peptide sequence confirmation, molecular weight verification, and formulation details to support method-level reproducibility and documentation control in research environments.• Analytical verification Each lot is qualified at 99% purity by high-performance liquid chromatography; peptide identity and molecular integrity are confirmed by mass spectrometry. Independent third-party laboratories corroborate in-house analytical results to maintain traceable quality metrics appropriate for research use.• Intended research use AOD 9604 is evaluated exclusively in controlled in-vitro systems investigating peptide-associated signaling pathways, metabolic pathway modulation models, and cellular signaling mechanisms under defined assay conditions. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes in humans or animals.• Research characteristics and applications AOD 9604 is characterized by a defined peptide sequence derived from a growth hormone fragment and is utilized as a research tool in analytical and cell-based models examining signaling cascades associated with metabolic regulation and cellular energy dynamics. In controlled in-vitro environments, researchers employ AOD 9604 to study pathway activation profiles, receptor-mediated signaling responses, intracellular communication networks, and comparative concentration-response relationships. Representative applications include assay development, mechanistic pathway investigations, time-course analyses, and cellular signaling characterization strictly within laboratory settings.Research Use Only (RUO) Statement • For in-vitro research only • Not for human or animal consumption • Not for diagnostic or therapeutic use
